SNDX - シンダックス・ファ―マシュ―ティカルズ (Syndax Pharmaceuticals Inc.)

SNDXのニュース

   Head to Head Review: Syndax Pharmaceuticals (NASDAQ:SNDX) vs. Iterum Therapeutics (NASDAQ:ITRM)  2021/03/13 00:27:10 Modern Readers
Syndax Pharmaceuticals (NASDAQ:SNDX) and Iterum Therapeutics (NASDAQ:ITRM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings. Volatility & Risk Syndax Pharmaceuticals has a beta of 1.8, suggesting that its share price […]
   Syndax Posts Better-Than-Feared Quarterly Loss, Sales Beat Estimates  2021/03/09 08:38:36 Smarter Analyst
Syndax Pharmaceuticals reported a better-than-expected loss in the fourth quarter and outpaced analysts’ expectations for revenues. Shares of the clinical-stage biopharmaceutical company dropped … The post Syndax Posts Better-Than-Feared Quarterly Loss, Sales Beat Estimates appeared first on Smarter Analyst .
   Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Increased to $29.00 by Analysts at Barclays  2020/11/20 13:08:52 Transcript Daily
Syndax Pharmaceuticals (NASDAQ:SNDX) had its price target lifted by Barclays from $23.00 to $29.00 in a report published on Thursday, The Fly reports. Barclays currently has an overweight rating on the stock. Other equities research analysts have also recently issued research reports about the stock. Zacks Investment Research cut shares of Syndax Pharmaceuticals from a […]
   The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration  2020/11/17 13:31:52 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 16) Aligos Therapeutics Inc (NASDAQ: ALGS ) (announced multiple presentations at the Liver Meeting) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Champions Oncology Inc (NASDAQ: CSBR ) CureVac BV (NASDAQ: CVAC )(announced a vaccine supply deal with the European Commission) Eidos Therapeutics Inc (NASDAQ: EIDX ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Kazia Therapeutics Ltd (NASDAQ: KZIA ) Keros Therapeutics Inc (NASDAQ: KROS ) Moderna Inc (NASDAQ: MRNA ) ( announced positive interim efficacy data for the Phase 3 study of its coronavirus vaccine candidate) Myokardia Inc (NASDAQ: MYOK ) Neuronetics Inc (NASDAQ: STIM ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Oncorus Inc (NASDAQ: ONCR ) Pacira Biosciences Inc (NASDAQ: PCRX ) Shockwave Medical Inc (NASDAQ: SWAV ) Spruce Biosciences Inc (NASDAQ: SPRB ) Summit Therapeutics Inc (NASDAQ: SMMT ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Tcr2 Therapeutics Inc (NASDAQ: TCRR ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) (announced regulatory filing for envafolimab in the indication of MSI-H/dMMR cancer, in China) Trinity Biotech plc (NASDAQ: TRIB ) United Therapeutics Corporation (NASDAQ: UTHR ) Veracyte Inc (NASDAQ: VCYT ) Vericel Corp (NASDAQ: VCEL ) Zai Lab Ltd – ADR (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov.
   Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 5.7%  2020/10/23 17:48:41 US Banking News
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) rose 5.7% during mid-day trading on Friday . The company traded as high as $16.18 and last traded at $16.01. Approximately 590,192 shares traded hands during mid-day trading, an increase of 20% from the average daily volume of 491,370 shares. The stock had previously closed at $15.14. SNDX has been the […]
   Head to Head Review: Syndax Pharmaceuticals (NASDAQ:SNDX) vs. Iterum Therapeutics (NASDAQ:ITRM)  2021/03/13 00:27:10 Modern Readers
Syndax Pharmaceuticals (NASDAQ:SNDX) and Iterum Therapeutics (NASDAQ:ITRM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, valuation and earnings. Volatility & Risk Syndax Pharmaceuticals has a beta of 1.8, suggesting that its share price […]
   Syndax Posts Better-Than-Feared Quarterly Loss, Sales Beat Estimates  2021/03/09 08:38:36 Smarter Analyst
Syndax Pharmaceuticals reported a better-than-expected loss in the fourth quarter and outpaced analysts’ expectations for revenues. Shares of the clinical-stage biopharmaceutical company dropped … The post Syndax Posts Better-Than-Feared Quarterly Loss, Sales Beat Estimates appeared first on Smarter Analyst .
   Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Increased to $29.00 by Analysts at Barclays  2020/11/20 13:08:52 Transcript Daily
Syndax Pharmaceuticals (NASDAQ:SNDX) had its price target lifted by Barclays from $23.00 to $29.00 in a report published on Thursday, The Fly reports. Barclays currently has an overweight rating on the stock. Other equities research analysts have also recently issued research reports about the stock. Zacks Investment Research cut shares of Syndax Pharmaceuticals from a […]
   The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration  2020/11/17 13:31:52 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 16) Aligos Therapeutics Inc (NASDAQ: ALGS ) (announced multiple presentations at the Liver Meeting) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Champions Oncology Inc (NASDAQ: CSBR ) CureVac BV (NASDAQ: CVAC )(announced a vaccine supply deal with the European Commission) Eidos Therapeutics Inc (NASDAQ: EIDX ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Kazia Therapeutics Ltd (NASDAQ: KZIA ) Keros Therapeutics Inc (NASDAQ: KROS ) Moderna Inc (NASDAQ: MRNA ) ( announced positive interim efficacy data for the Phase 3 study of its coronavirus vaccine candidate) Myokardia Inc (NASDAQ: MYOK ) Neuronetics Inc (NASDAQ: STIM ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Oncorus Inc (NASDAQ: ONCR ) Pacira Biosciences Inc (NASDAQ: PCRX ) Shockwave Medical Inc (NASDAQ: SWAV ) Spruce Biosciences Inc (NASDAQ: SPRB ) Summit Therapeutics Inc (NASDAQ: SMMT ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Tcr2 Therapeutics Inc (NASDAQ: TCRR ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) (announced regulatory filing for envafolimab in the indication of MSI-H/dMMR cancer, in China) Trinity Biotech plc (NASDAQ: TRIB ) United Therapeutics Corporation (NASDAQ: UTHR ) Veracyte Inc (NASDAQ: VCYT ) Vericel Corp (NASDAQ: VCEL ) Zai Lab Ltd – ADR (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov.
   Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 5.7%  2020/10/23 17:48:41 US Banking News
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) rose 5.7% during mid-day trading on Friday . The company traded as high as $16.18 and last traded at $16.01. Approximately 590,192 shares traded hands during mid-day trading, an increase of 20% from the average daily volume of 491,370 shares. The stock had previously closed at $15.14. SNDX has been the […]
   Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Increased to $29.00 by Analysts at Barclays  2020/11/20 13:08:52 Transcript Daily
Syndax Pharmaceuticals (NASDAQ:SNDX) had its price target lifted by Barclays from $23.00 to $29.00 in a report published on Thursday, The Fly reports. Barclays currently has an overweight rating on the stock. Other equities research analysts have also recently issued research reports about the stock. Zacks Investment Research cut shares of Syndax Pharmaceuticals from a […]
   The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration  2020/11/17 13:31:52 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 16) Aligos Therapeutics Inc (NASDAQ: ALGS ) (announced multiple presentations at the Liver Meeting) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Champions Oncology Inc (NASDAQ: CSBR ) CureVac BV (NASDAQ: CVAC )(announced a vaccine supply deal with the European Commission) Eidos Therapeutics Inc (NASDAQ: EIDX ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Kazia Therapeutics Ltd (NASDAQ: KZIA ) Keros Therapeutics Inc (NASDAQ: KROS ) Moderna Inc (NASDAQ: MRNA ) ( announced positive interim efficacy data for the Phase 3 study of its coronavirus vaccine candidate) Myokardia Inc (NASDAQ: MYOK ) Neuronetics Inc (NASDAQ: STIM ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Oncorus Inc (NASDAQ: ONCR ) Pacira Biosciences Inc (NASDAQ: PCRX ) Shockwave Medical Inc (NASDAQ: SWAV ) Spruce Biosciences Inc (NASDAQ: SPRB ) Summit Therapeutics Inc (NASDAQ: SMMT ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Tcr2 Therapeutics Inc (NASDAQ: TCRR ) TRACON Pharmaceuticals Inc (NASDAQ: TCON ) (announced regulatory filing for envafolimab in the indication of MSI-H/dMMR cancer, in China) Trinity Biotech plc (NASDAQ: TRIB ) United Therapeutics Corporation (NASDAQ: UTHR ) Veracyte Inc (NASDAQ: VCYT ) Vericel Corp (NASDAQ: VCEL ) Zai Lab Ltd – ADR (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov.
   Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 5.7%  2020/10/23 17:48:41 US Banking News
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) rose 5.7% during mid-day trading on Friday . The company traded as high as $16.18 and last traded at $16.01. Approximately 590,192 shares traded hands during mid-day trading, an increase of 20% from the average daily volume of 491,370 shares. The stock had previously closed at $15.14. SNDX has been the […]
   The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test  2020/05/20 12:12:06 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 19) ADC Therapeutics SA (NYSE: ADCT ) (IPOed May 15) Allogene Therapeutics Inc (NASDAQ: ALLO ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) BioXcel Therapeutics Inc (NASDAQ: BTAI ) ChemoCentryx Inc (NASDAQ: CCXI ) Evoke Pharma Inc (NASDAQ: EVOK ) I-Mab ADR (NASDAQ: IMAB ) Imara Inc (NASDAQ: IMRA ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Syndax Pharmaceuticals Inc (NASDAQ: SNDX ) Translate Bio Inc (NASDAQ: TBIO ) Twist Bioscience Corp (NASDAQ: TWST ) United Therapeutics Corporation (NASDAQ: UTHR ) VBI Vaccines Inc (NASDAQ: VBIV ) Vermillion, Inc. (NASDAQ: VRML ) Zai Lab Ltd (NASDAQ: ZLAB ) Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 19) Lyra Therapeutics Inc (NASDAQ: LYRA ) (IPOed May 1) Stocks In Focus Myriad Announces FDA Approval For Companion Diagnostic Test For Prostate Cancer Myriad Genetics, Inc. (NASDAQ: MYGN ) said the FDA approved the BRACAnalysis CDx test for use as a companion diagnostic by healthcare professionals to identify men with metastatic castration-resistant prostate cancer who are eligible for treatment with Lynparza.
   The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update  2020/04/28 11:36:28 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) AstraZeneca plc (NYSE: AZN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) BioSig Technologies Inc (NASDAQ: BSGM ) Black Diamond Therapeutics Inc (NASDAQ: BDTX ) Cytosorbents Corp (NASDAQ: CTSO ) DexCom, Inc. (NASDAQ: DXCM ) Erytech Pharma SA (NASDAQ: ERYP ) Exelixis, Inc. (NASDAQ: EXEL ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) I-Mab ADR (NASDAQ: IMAB ) Imara Inc (NASDAQ: IMRA ) Incyte Corporation (NASDAQ: INCY ) Kala Pharmaceuticals Inc (NASDAQ: KALA ) Keros Therapeutics Inc (NASDAQ: KROS ) Masimo Corporation (NASDAQ: MASI ) Novo Nordisk A/S (NYSE: NVO ) OraSure Technologies, Inc. (NASDAQ: OSUR ) Quidel Corporation (NASDAQ: QDEL ) REDHILL BIOPHAR/S ADR (NASDAQ: RDHL ) Repligen Corporation (NASDAQ: RGEN ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Translate Bio Inc (NASDAQ: TBIO ) Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ) Vaxart Inc (NASDAQ: VXRT ) Vermillion, Inc. (NASDAQ: VRML ) West Pharmaceutical Services Inc. (NYSE: WST ) Y-mAbs Therapeutics, Inc (NASDAQ: YMAB ) Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL ) Zynex Inc. (NASDAQ: ZYXI ) None of the Nasdaq- or NYSE-listed biotech/medical device/diagnostics company hit 52-week lows Monday.

calendar